BB BIOTECH AG
CIK 924223 · last filed 2025-03-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$64.21M
Companies
7
Total Filings
121
Lifetime Open-Market Net
$513.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDTX | 10%+ Owner | 7,517,839 | $1.76 | $13.23M | $13.50M | 10 | 2025-03-20 |
| ESSA Pharma Inc. (EPIX) Delisted | 10%+ Owner | 3,879,583 | $0.20 | $780.6K | $1.89M | 6 | 2024-11-05 |
| Molecular Templates, Inc. (MTEM) Delisted | 10%+ Owner | 1,279,820 | $0.00 | $128 | $95.56M | 18 | 2024-04-04 |
| MGNX | 10%+ Owner | 9,929,963 | $3.70 | $36.74M | $66.52M | 10 | 2023-10-04 |
| Radius Health, Inc. (RDUS) Delisted | 10%+ Owner | 8,733,538 | $30.00 | $262.01M | $250.58M | 58 | 2022-05-20 |
| ESPR | 10%+ Owner | 4,477,964 | $3.18 | $14.24M | $84.78M | 16 | 2021-05-26 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | 10%+ Owner | 114,764 | $221.38 | $25.41M | $907.9K | 1 | 2017-11-16 |
Recent Filings · Page 3 of 13
121 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-29 | BDTX | Buy (P) | +811,422 | $2.11M | EDGAR |
| 2022-04-28 | ESSA Pharma Inc. (EPIX) Delisted | Sell (S) | −50,200 | -$293.9K | EDGAR |
| 2022-04-20 | BDTX | Buy (P) | +600,000 | $1.96M | EDGAR |
| 2022-04-14 | BDTX | Buy (P) | +505,112 | $1.76M | EDGAR |
| 2022-01-10 | Molecular Templates, Inc. (MTEM) Delisted | Buy (P) | +400,000 | $1.61M | EDGAR |
| 2021-11-23 | MGNX | Buy (P) | +400,000 | $7.40M | EDGAR |
| 2021-10-01 | Radius Health, Inc. (RDUS) Delisted | Buy (P) | +200,000 | $2.59M | EDGAR |
| 2021-09-30 | MGNX | Buy (P) | +400,000 | $8.22M | EDGAR |
| 2021-09-24 | Radius Health, Inc. (RDUS) Delisted | Buy (P) | +300,000 | $3.68M | EDGAR |
| 2021-09-23 | Molecular Templates, Inc. (MTEM) Delisted | Buy (P) | +1,500,000 | $9.00M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.